Stay updated with breaking news from Eric Ducournau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Scorpion receives $65 million from an upfront payment and the achievement of near-term milestones and is eligible to receive up to $553 million in potential milestones, plus royalties on net product
Scorpion receives $65 million from an upfront payment and the achievement of near-term milestones and is eligible to receive up to $553 million in potential milestones, plus royalties on net
Following transfer of the EC marketing authorisation from Atara, Pierre Fabre will lead commercialisation of EBVALLO® in Europe.
Pierre Fabre to Lead Launch and Commercialization Activities for EBVALLO In Europe Following Transfer of European Commission Marketing Authorization from Atara Biotherapeutics EBVALLO is the
/PRNewswire/ -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), and Pierre Fabre today announced that the European Commission (EC) has granted marketing...